Skip to main content
logo
Day One Biopharmaceuticals, Inc. (DAWN)
NASDAQ: DAWN · Real-Time Price · USD
11.35
+0.35 (3.18%)
At close: Feb 13, 2026, 4:00 PM EST
11.36
+0.01 (0.09%)
After-hours: Feb 13, 2026, 7:16 PM EST

DAWN Revenue

Day One Biopharmaceuticals had revenue of $39.80M in the quarter ending September 30, 2025, a decrease of -57.56%. This brings the company's revenue in the last twelve months to $133.67M, up 31.11% year-over-year. In the year 2024, Day One Biopharmaceuticals had annual revenue of $131.16M.

Revenue (ttm)
$133.67M
Revenue Growth
+31.11%
P/S Ratio
8.74
Revenue / Employee
$726,478
Employees
184
Market Cap
1.17B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024131.16M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pharming Group362.27M
Xeris Biopharma Holdings266.14M
EyePoint42.34M
Septerna22.05M
Inventiva19.93M
Vir Biotechnology16.86M
Nanobiotix11.93M
Capricor Therapeutics11.13M
Revenue Rankings

DAWN News

More News